Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Sumitomo Dainippon Pharma discloses TLR7 antagonists

Nov. 20, 2017

Phase III HAVEN 3 study of emicizumab in hemophilia A meets endpoints

Nov. 20, 2017

FDA first to approve Hemlibra for hemophilia A

Nov. 17, 2017

Shire's Adynovi receives positive opinion in E.U.

Nov. 14, 2017

EMA's CHMP supports expanding Nplate indication

Nov. 13, 2017

Alnylam reaches alignment with FDA on safety measures for fitusiran program

Nov. 10, 2017

Memantine improves red blood cell parameters, quality of life in sickle cell patients

Nov. 8, 2017

FDA gives fast track designation to imetelstat for lower risk MDS

Nov. 2, 2017

New lower dose of rivaroxaban approved by FDA

Oct. 31, 2017

European Commission approves new indication for Firazyr

Oct. 27, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...